companydata.dkcompanydata.dk

STRAGEN NORDIC A/S: Financial statements 2020

CVR: 26717825

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 6,764,350 and a net result of DKK 2,602,117 compared with DKK 1,741,348 the year before. That is a decrease of 3.7% compared with the year before. Equity in the 2020 report amounted to DKK 9,712,058. The solvency ratio was 42.3%. The company had 6 employees in the financial year.

Gross Profit
DKK 6,764,350
Profit/Loss
DKK 2,602,117
Equity
DKK 9,712,058
Total Assets
DKK 22,965,213
Employees
6

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-6.8M2.6M9.7M6
2019-7M1.7M7.1M6
2018-5.5M1.9M5.4M-
2017-4.1M497K3.5M-
2016-4.2M702K3.3M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is STRAGEN NORDIC A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

STRAGEN NORDIC A/S: The 2019 annual report is outMay 20, 2020

STRAGEN NORDIC A/S has published its annual report for 2019. Gross profit came to DKK 7,024,337, and the net result was DKK 1,741,348.

Jean-Baptiste Pierre Marie Amadieu joins the board of STRAGEN NORDIC A/SApr 30, 2020

As of April 30, 2020, Jean-Baptiste Pierre Marie Amadieu has joined the board of directors of STRAGEN NORDIC A/S.

Antoine Tétard leaves the board of STRAGEN NORDIC A/SApr 30, 2020

As of April 30, 2020, Antoine Tétard has left the board of directors of STRAGEN NORDIC A/S.

About STRAGEN NORDIC A/S

STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.

Source: annual report 2025, Danish Business Authority